IFRX - inflarx.de Qarzning balans kapitallashuviga nisbati
Hukumat subsidiyalari InflaRx N.V. (IFRX) uchun kapital risklarini minimallashtirsa-da, yetakchi nemis immunologlarini jalb qilish sezilarli investitsiyalarni talab qiladi. GURU.Markets platformasidagi qarzning kitob qiymatiga nisbati tarixiy ma'lumotlari ushbu omillarni muvozanatga keltirishga yordam beradi, bunda ko'rsatkich hozirda 0.01 darajasida turibdi. Moliyaviy barqarorlik yangi terapevtik molekulalarni kashf etishni avtomatlashtiruvchi laboratoriya robototexnikasining joriy etilishi bilan yanada mustahkamlandi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_IFRX_-_InflaRx-N.V._-_Debt-to-Net-Assets-Ratio "InflaRx NV - IFRX Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
inflarx.de (IFRX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahliliyoti:InflaRx GmbH (IFRX)
Ushbu koeffitsiyent umumiy majburiyatlar va kapital o'rtasidagi bog'liqlikni aks ettirib, biznesning qarz mablag'lariga bog'liqlik darajasini belgilaydi. Ushbu koeffitsiyentning oshishi moliyaviy xatarlarning ortishi va barqarorlikning potensial yo'qolishi signalini beradi. Kompaniyaning qarzning kitob qiymatidagi kapitalizatsiyaga nisbati koeffitsiyentini tahlil qilish orqali investor leveraj dinamikasini kuzatishi mumkin. InflaRx N.V. (IFRX) uchun klinik sinovlarni moliyalashtirishda majburiyatlar muvozanatini saqlash juda muhimdir. Qarzlar optimallashtirilishi esa mualliflik antitelalarning tijoratlashtirish jarayonida maksimal marjalarni ta'minlaydi.
InflaRx N.V. kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Zenas Bio ZBIO|Balans kapitallashuviga qarzlar IMNM (Immunome Corp)|GOSS: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati KalVista Pharmaceuticals|septerna.com (SEPN) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Pieris Pharmaceuticals, Inc. PVLA|Qarzlarning balans kapitallashuviga nisbati SVRA|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc (RIGL)|Qarzning balans kapitallashuviga nisbati AnaptysBio Inc. (ANAB)|Balans kapitallashuviga qarzlar ATXS (Astria Therapeutics)|engene.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati RAPT Therapeutics, Inc. (RAPT)|Aerovate Therapeutics Inc (JBIO) - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati Aclaris|Qarzning balans qiymatiga nisbati Kyverna Therapeutics, Inc|TLSA - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati CABA|Qarzning balans kapitallashuviga nisbati Ventyx Biosciences, Inc. VTYX|Qarzning balans qiymatiga nisbati Theratechnologies, Inc. THTX|Qarzning balans qiymatiga nisbati AVTX|ELDN - Sof aktivlarga qarzlar|AGEN - Qarzning balans qiymatiga nisbati|climbbio.com (CLYM) - Qarzning balans kapitallashuviga nisbati|Zura Bio Limited - Qarzning balans qiymatiga nisbati|aTyr Pharma Inc (ATYR) - Sof aktivlarga qarzlar|ADAG: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Ikena Oncology, Inc.|STTK - Balans kapitallashuviga qarzlar|Qarzlarning balans kapitallashuviga nisbati EQ (equilliumbio.com)|Qarzning balans kapitallashuviga nisbati Connect Biopharma Holdings Limited|IMUX - Qarzning sof aktivlarga nisbati|Atara Biotherapeutics Inc (ATRA) - Qarzning balans qiymatiga nisbati|XFOR: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati adicetbio.com (ACET)|Celularity (CELU) - Qarzlarning balans kapitallashuviga nisbati|INMB - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Barinthus Biotherapeutics PLC|Balans kapitallashuviga qarzlar KZR|Balans kapitallashuviga qarzlar SABS (SAB Biotherapeutics Inc)|Qarzning balans kapitallashuviga nisbati Akari Therapeutics|Enlivex Therapeutics Ltd - Qarzning sof aktivlarga nisbati|QTTB: Qarzning balans kapitallashuviga nisbati|GOVX - Qarzning balans qiymatiga nisbati|EDSA: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar iBio Corporation|CARM - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati xtlbio.com|BOLT (Bolt Biotherapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar HCWB (hcwbiologics.com)|Aptevo Therapeutics Inc. - Qarzning balans kapitallashuviga nisbati|AIM ImmunoTech, Inc. - Qarzning balans qiymatiga nisbati|ADTX: Qarzning balans kapitallashuviga nisbati|gribio.com (GRI) - Qarzning balans qiymatiga nisbati|XRTX: Qarzning balans qiymatiga nisbati|HIND (Vyome Holdings Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Revelation Bio (REVB)|Qarzning balans qiymatiga nisbati Indaptus Corp|Scinai Immunotherapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar calcimedica.com (CALI)|Balans kapitallashuviga qarzlar AFMD|Allakos Inc - Sof aktivlarga qarzlar|HOOKIPA (HOOK) - Qarzning balans kapitallashuviga nisbati|IGMS - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar iTeos Therapeutics (ITOS)|OCEA (oceanbiomedical.com) - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati TC BioPharm|Qarzning balans kapitallashuviga nisbati Third Harmonic Bio Inc.